Zobrazeno 1 - 10
of 181
pro vyhledávání: '"Renzo Caprilli"'
Autor:
Danila Guagnozzi, Renzo Caprilli
Publikováno v:
Biologics: Targets & Therapy, Vol 2008, Iss Issue 2, Pp 275-284 (2008)
Danila Guagnozzi, Renzo CaprilliGastroenterology Unit, Department of Clinical Sciences, University of Rome “La Sapienza”, Rome, ItalyAbstract: The pathogenesis of Crohn’s disease (CD) is multifactorial and the activation of specific pathways of
Externí odkaz:
https://doaj.org/article/53acc0a5dee3463594f9905aac2d678d
Autor:
Mark S Silverberg, Jack Satsangi, Tariq Ahmad, Ian DR Arnott, Charles N Bernstein, Steven R Brant, Renzo Caprilli, Jean-Frédéric Colombel, Christoph Gasche, Karel Geboes, Derek P Jewell, Amir Karban, Edward V Loftus, A Salvador Peña, Robert H Riddell, David B Sachar, Stefan Schreiber, A Hillary Steinhart, Stephan R Targan, Severine Vermeire, Bryan F Warren
Publikováno v:
Canadian Journal of Gastroenterology, Vol 19, Iss Suppl A, Pp 5A-36A (2005)
The discovery of a series of genetic and serological markers associated with disease susceptibility and phenotype in inflammatory bowel disease has led to the prospect of an integrated classification system involving clinical, serological and genetic
Externí odkaz:
https://doaj.org/article/168e8fa578624d5da5d8ebf28b2082c4
Publikováno v:
Journal of Crohn's and Colitis. 8:903-918
Background and aims Treatment of inflammatory bowel diseases (IBD) is only aimed to block or inhibit the pathogenetic steps of the inflammatory cascade. Side effects of systemic therapies, poor targeting of orally administered topical drug and low ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c27a8e039cb6dcb2da82394fa4e410b5
https://doi.org/10.1016/j.crohns.2014.02.024
https://doi.org/10.1016/j.crohns.2014.02.024
Publikováno v:
Journal of Crohn's and Colitis. 6:621-625
Inflammatory bowel diseases (IBDs), encompassing ulcerative colitis (UC) and Crohn's disease (CD) are chronic, progressive and relapsing pathologic conditions caused by a dysregulation of the immune system.1 IBDs are characterised by inflammation and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17242d2dc6a615ca2783f66fc313b2b2
https://doi.org/10.1016/j.crohns.2012.02.009
https://doi.org/10.1016/j.crohns.2012.02.009
Publikováno v:
Journal of Crohn's and Colitis. 4:377-383
Several old and new observations suggest the existence in Crohn's disease of a phagocytic disorder of macrophages related to impaired bactericidal activity of host cells or to the presence of invasive bacteria that have developed strategies to counte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::504691fc7f263d07b77341e360a4b311
https://doi.org/10.1016/j.crohns.2010.05.007
https://doi.org/10.1016/j.crohns.2010.05.007
Publikováno v:
Journal of Crohn's and Colitis. 3:149-156
The advent of salicylates in the treatment of ulcerative colitis started in 1938 with the discovery of Salazopyrin by Nanna Svartz. This drug offered for the first time a therapeutic chance to patients with ulcerative colitis. In this paper we descri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82f1c2c4e2221bc53c596c07eada4334
https://doi.org/10.1016/j.crohns.2009.05.001
https://doi.org/10.1016/j.crohns.2009.05.001
Autor:
Renzo Caprilli
Publikováno v:
Journal of Crohn's and Colitis. 2:352-356
Crohn's disease can affect any part of the gastrointestinal tract, but terminal ileum is the most frequent localization. The reason why Crohn's disease is primarily located in the distal part of the ileum remains unexplained. In this article it has b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b2c9c1b78b20596e8f5314ad70efca2
https://doi.org/10.1016/j.crohns.2008.06.001
https://doi.org/10.1016/j.crohns.2008.06.001
Autor:
Lucio Capurso, Claudio Papi, Angelo Viscido, Renzo Caprilli, Annalisa Aratari, Gioacchino Leandro
Publikováno v:
Alimentary Pharmacology & Therapeutics. 26:1303-1312
Summary Background Surgical resection is almost inevitable in Crohn’s disease. Surgery is usually performed for refractory or complicated disease: no studies appear to have been carried out, so far, to evaluate the potential benefits of performing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84b6093dc30db8359c273280bbcf8ab7
https://doi.org/10.1111/j.1365-2036.2007.03515.x
https://doi.org/10.1111/j.1365-2036.2007.03515.x
Autor:
G.C. Sturniolo, Renzo Caprilli, Orazio Palmieri, Salvatore Cucchiara, Renata D'Incà, Angelo Andriulli, Vito Annese, Fabrizio Bossa, Anna Latiano, Maria Rosa Valvano
Publikováno v:
Alimentary Pharmacology & Therapeutics. 27:241-248
Summary Background Variants of myosin IXB (MYO9B) gene, encoding for a motor protein implicated in epithelial permeability, have been recently associated with inflammatory bowel disease. Aims To investigate the contribution of three polymorphisms of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8925cc5e2f5d084c009f283db98dcc1f
https://doi.org/10.1111/j.1365-2036.2007.03551.x
https://doi.org/10.1111/j.1365-2036.2007.03551.x
Publikováno v:
Inflammatory Bowel Diseases. 13:1031-1050
At the “4th International Meeting on Inflammatory Bowel Diseases: on the Way to New Therapies,” Capri, 2006, genetics, bacteria–host interactions, immunomodulation, and tissue response were discussed deeply in order to understand, rationalize,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62f7c1121f12bbbba63ef9665028666a
https://doi.org/10.1002/ibd.20127
https://doi.org/10.1002/ibd.20127